LEVOFAR Injection 12.5 mg/ml | Levosulpiride Injection

LEVOFAR Injection

  • Home
  • LEVOFAR Injection
LEVOFAR Injection

LEVOFAR Injection

Composition : Levosulpiride Injection IP 12.5 mg/ml

Packing : 5 × 2 ml Ampoules

MRP : 98/-

Enquire Now


Can't read the image? click here to refresh

LEVOFAR – Levosulpiride Injection 12.5 mg/ml

LEVOFAR is a pharmaceutical injectable formulation containing Levosulpiride at a concentration of 12.5 mg/ml. It is presented in a 2 ml ampoule format, with five ampoules supplied in each pack.

Levosulpiride belongs to the substituted benzamide class of compounds and exhibits dopamine D2 receptor antagonist activity. Its pharmacological properties are associated with dopaminergic pathways and gastrointestinal motility.

Product Composition

Each ml contains Levosulpiride 12.5 mg.

Formulation Details

  • Brand Name: LEVOFAR

  • Generic Name: Levosulpiride

  • Strength: 12.5 mg/ml

  • Dosage Form: Injection

  • Packing: 5 × 2 ml Ampoules

  • Route Mentioned on Pack: Intravenous (I.V.) / Intramuscular (I.M.)

Pharmacological Information

Levosulpiride acts primarily through dopamine D2 receptor antagonism. Its pharmacological activity is relevant to gastrointestinal motility and certain neurological pathways.

Important Information

LEVOFAR is a prescription injectable formulation. Administration, dosage and route selection must be determined by a qualified healthcare professional in accordance with approved prescribing information.

The product should be used only under appropriate medical supervision.